These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
291 related items for PubMed ID: 29554650
1. Dysregulated MiR-3150a-3p Promotes Lumbar Intervertebral Disc Degeneration by Targeting Aggrecan. Zhang B, Guo W, Sun C, Duan HQ, Yu BB, Mu K, Guan YY, Li Y, Liu S, Liu Y, Ban DX, Ruan WD, Kong XH, Xing C, Ning GZ, Feng SQ. Cell Physiol Biochem; 2018; 45(6):2506-2515. PubMed ID: 29554650 [Abstract] [Full Text] [Related]
4. Targeting of CDKN1B by miR-222-3p may contribute to the development of intervertebral disc degeneration. Liu J, Yu J, Jiang W, He M, Zhao J. FEBS Open Bio; 2019 Apr; 9(4):728-735. PubMed ID: 30984546 [Abstract] [Full Text] [Related]
5. LncRNA OIP5-AS1 accelerates intervertebral disc degeneration by targeting miR-25-3p. Che Z, Xueqin J, Zhang Z. Bioengineered; 2021 Dec; 12(2):11201-11212. PubMed ID: 34872452 [Abstract] [Full Text] [Related]
6. MicroRNA-132 upregulation promotes matrix degradation in intervertebral disc degeneration. Liu W, Xia P, Feng J, Kang L, Huang M, Wang K, Song Y, Li S, Wu X, Yang S, Yang C. Exp Cell Res; 2017 Oct 01; 359(1):39-49. PubMed ID: 28793234 [Abstract] [Full Text] [Related]
8. Downregulation of microRNA-193a-3p is involved in invertebral disc degeneration by targeting MMP14. Ji ML, Zhang XJ, Shi PL, Lu J, Wang SZ, Chang Q, Chen H, Wang C. J Mol Med (Berl); 2016 Apr 01; 94(4):457-68. PubMed ID: 26620678 [Abstract] [Full Text] [Related]
9. MicroRNA-140-3p alleviates intervertebral disc degeneration via KLF5/N-cadherin/MDM2/Slug axis. Wang Z, Zhang S, Zhao Y, Qu Z, Zhuang X, Song Q, Leng J, Liu Y. RNA Biol; 2021 Dec 01; 18(12):2247-2260. PubMed ID: 33904383 [Abstract] [Full Text] [Related]
14. LncRNA-RMRP promotes nucleus pulposus cell proliferation through regulating miR-206 expression. Wang X, Peng L, Gong X, Zhang X, Sun R, Du J. J Cell Mol Med; 2018 Nov 01; 22(11):5468-5476. PubMed ID: 30156374 [Abstract] [Full Text] [Related]
15. Nucleus Pulposus-Targeting Nanocarriers Facilitate Mirna-Based Therapeutics for Intervertebral Disc Degeneration. Chen Z, Liao Z, Liu M, Lin F, Chen S, Wang G, Zheng Z, Liu B, Li C, Wang Z, Chen T, Huang H, Liao Q, Cui W. Adv Healthc Mater; 2023 Nov 01; 12(28):e2301337. PubMed ID: 37625164 [Abstract] [Full Text] [Related]
17. Inflammation-dependent downregulation of miR-194-5p contributes to human intervertebral disc degeneration by targeting CUL4A and CUL4B. Chen Z, Han Y, Deng C, Chen W, Jin L, Chen H, Wang K, Shen H, Qian L. J Cell Physiol; 2019 Nov 01; 234(11):19977-19989. PubMed ID: 30945295 [Abstract] [Full Text] [Related]
19. CircSEMA4B targets miR-431 modulating IL-1β-induced degradative changes in nucleus pulposus cells in intervertebral disc degeneration via Wnt pathway. Wang X, Wang B, Zou M, Li J, Lü G, Zhang Q, Liu F, Lu C. Biochim Biophys Acta Mol Basis Dis; 2018 Nov 01; 1864(11):3754-3768. PubMed ID: 30251693 [Abstract] [Full Text] [Related]
20. MiR-210 facilitates ECM degradation by suppressing autophagy via silencing of ATG7 in human degenerated NP cells. Wang C, Zhang ZZ, Yang W, Ouyang ZH, Xue JB, Li XL, Zhang J, Chen WK, Yan YG, Wang WJ. Biomed Pharmacother; 2017 Sep 01; 93():470-479. PubMed ID: 28667916 [Abstract] [Full Text] [Related] Page: [Next] [New Search]